Transdermal Immunisation With an Integral Membrane Component,
Gap Junction Protein, by Means of Ultradeformable Drug Carriers, Transfersomes
A. Paul*+, G. Cevc* and B. K. Bachhawat+
*Medizinische Biophysik, Technische Universität München
Klinikum r.d.I., Ismaningerstr. 22 D-81675 München (Germany), E.U.
+Department of Biochemistry, University of Delhi (South Campus) Benito
Juarez Road, New Delhi 110021, India
Vaccine 16: 188-195 (1998).
Molecules greater than 500 Da normally do not cross the
skin. This prevents epicutaneous delivery of the high molecular weight
therapeutics as well as non-invasive transcutaneous immunisation. Extremely
deformable vesicles prepared by the judicious combination of several materials
provide a solution to this problem: the resulting agent carriers, transfersomes,
are the only tested colloidal system that can transport even large macromolecules
spontaneously through the skin in immunologically active form. Gap junction
proteins (GJP) incorporated into transfersomes and applied on the intact
skin surface thus give rise to the specific antibody titres marginally
higher than those elicited by the subcutaneous injections of GJP in transfersomes,
mixed lipid micelles or liposomes. The latter two carrier systems give
no significant biological response after epicutaneous administration.
Transcutaneous protein delivery by means of transfersomes also appears
to increase the relative concentration of anti-GJP IgA in the serum.
<---- |
Home |
About us |
Corporate Factsheet |
Science |
Publications |
Product opportunities |
Finance |
Press releases |
Latest newsletter |
Press clippings |
Conferences |
Career |
Contact |
Scientific FAQ |
Glossary |
Site Map |
Search |